Edwards Lifesciences Gets Approval for Tricuspid Valve Repair System From US FDA

10:13 AM EDT, 10/21/2026 (MT Newswires) -- Edwards Lifesciences (EW) has obtained approval for its PASCAL Precision system for tricuspid valve repair from the US Food and Drug Administration, the company said Wednesday. The system is indicated for improving quality of life and functional status in patients with symptomatic severe tricuspid regurgitation, according to a statement. The agency has also approved the PASCAL Ace with Capture Clarity system for use in degenerative mitral transcatheter edge-to-edge repair procedures, the company said. Price: 87.59, Change: -0.70, Percent Change: -0.79